EVALUATION OF THE EFFICACY OF MOROCTOCOG ALPHA DURING THE PREVENTIVE TREATMENT OF PATIENTS WITH HEMOPHILIA A

EHA Library, Valery Voitsekhovsky, 324145

COVID INFECTION REVEALING FACTOR XI DEFICIENCY IN ELDERLY PATIENT

EHA Library, hajar khibri, 324146

APLASTIC ANEMIA PATIENTS COULD BE DIVIDED INTO TWO SUBGROUPS BASED ON THE GENE EXPRESSION IN THEIR BONE MARROW MULTIPOTENT MESENCHYMAL STROMAL CELLS

EHA Library, Alena Dorofeeva, 324147

IDENTIFICATION OF A NOVEL DELETION IN THE RPS26 GENE IN A GREEK CHILD WITH THE DIAGNOSIS OF BLACKFAN-DIAMOND ANEMIA

EHA Library, Iordanis Pelagiadis, 324148

PROFILE OF HEMOPHAGOCYTIC LYMPOHISTIOCYTOSIS (HLH) – PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Sirisharani Siddaiahgari, 324149

LONG-TERM EFFECTS IN SUBGROUPS OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN VERSUS ECULIZUMAB: 48-WEEK ANALYSIS OF PEGASUS PHASE 3 TRIAL

EHA Library, Regis Peffault De La Tour, 324150

RHTPO IMPROVES THE OVERALL SURVIVAL OF PATIENTS WITH APLASTIC ANEMIA IN CHINA: RETROSPECTIVE ANALYSIS OF A SINGLE-INSTITUTION

EHA Library, rong Fu, 324151

MUTATION ANALYSIS OF CHINESE SPORADIC DIAMOND-BLACKFAN ANEMIA BY NEXT GENERATION SEQUENCING

EHA Library, Jing Li, 324152

IDIOPATHIC APLASTIC ANEMIA – ARE THERE OTHER PROGNOSTIC FACTORS?

EHA Library, Catia Reis, 324153

INJECTION-SITE REACTIONS AT WEEK 48 IN THE RANDOMIZED PHASE 3 PEGASUS TRIAL OF PEGCETACOPLAN COMPARED WITH ECULIZUMAB FOR INDIVIDUALS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Vivek Sharma, 324154

PH3 STUDY OF EFFICACY AND SAFETY OF IPTACOPAN (LNP023), AN ORAL COMPLEMENT FACTOR B INHIBITOR, IN PTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND RESIDUAL ANEMIA DESPITE ANTI-C5 ANTIBODY TREATMENT

EHA Library, Antonio Risitano, 324155

CATEGORIZED HEMATOLOGIC RESPONSE TO PEGCETACOPLAN VERSUS ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: POST HOC ANALYSIS OF PEGASUS PHASE 3 RANDOMIZED TRIAL DATA

EHA Library, Antonio Risitano, 324156

ASSOCIATION BETWEEN HLA AND BONE MARROW FAILURE DISEASES

EHA Library, Yuanyuan Shao, 324157

POST COVID 19 APLASTIC ANEMIA: CASE REPORT

EHA Library, Doaa El Demerdash , 324158

TWO CURRENTLY RECRUITING PHASE III TRIALS: COMMODORE 1 AND 2 EVALUATING CROVALIMAB VS ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WITH OR WITHOUT CURRENT ANTI–COMPLEMENT THERAPY

EHA Library, Austin Kulasekararaj, 324159

PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF IPTACOPAN (LNP023), AN ORAL FACTOR B INHIBITOR, IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) NAÏVE TO COMPLEMENT INHIBITOR THERAPY

EHA Library, Regis Peffault De La Tour, 324160

PHENOTYPE-GENOTYPE RELATIONSHIP IN PATIENTS WITH FANCONI ANEMIA AND VACTERL-H ASSOCIATION FREQUENCY

EHA Library, Canan Albayrak, 324161

DIAGNOSIS OF HEMATOPOIETIC MALIGNANCIES WITH GERMLINE PREDISPOSITION : A FILTERED WHOLE EXOME SEQUENCING APPROACH

EHA Library, Rafael Fernandez Carazo, 324162

REAL WORLD SINGLE CENTRE EXPERIENCE OF USE OF ELTROMBOPAG ADDED TO STANDARD IMMUNOSUPPRESSION AMONG INDIAN PATIENTS WITH APLASTIC ANEMIA

EHA Library, Radhika K.K, 324163

COMPARATIVE EFFECTIVENESS OF PEGCETACOPLAN VERSUS RAVULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A MATCHING-ADJUSTED INDIRECT COMPARISON USING 26 WEEK PEGASUS PHASE 3 TRIAL DATA

EHA Library, Rachel Bhak, 324164

TRIAL IN PROGRESS: QUANTIFYING THE HUMANISTIC AND SOCIOECONOMIC BURDEN OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE COMMODORE BURDEN OF ILLNESS STUDY

EHA Library, Roger James Hampton, 324165

EPIDEMIOLOGY OF ACQUIRED APLASTIC ANEMIA: A RETROSPECTIVE 10-YEAR SINGLE CENTRE EXPERIENCE

EHA Library, Liri Seraj, 324166

RETROSPECTIVE ANALYSIS OF ROMIPLOSTIN IN SEVERE MEDULLARY APLASIA

EHA Library, Ana Rosa Carranco Falcón, 324167

BONE MARROW METASTASIS: A CASE SERIES

EHA Library, Siew Lian Chong, 324168

GENETIC LESIONS IN CLL PATIENTS WITH STEREOTYPE ANTIGENIC RECEPTORS MOST COMMON IN RUSSIA.

EHA Library, Bella Biderman, 324169

TARGETED MULTIGENE PANEL: NEXT-GENERATION SEQUENCING IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Maria Mikhaleva, 324170

CLINICAL FEATURES OF LARGE GRANULAR LYMPHOCYTIC LEUKEMIA-ASSOCIATED PURE RED CELL APLASIA: RESULTS FROM A SINGLE CENTER IN CHINA

EHA Library, Meili Ge, 324171

A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED WITH VENETOCLAX IN THE REAL-LIFE SETTING IN SPAIN (VENARES)

EHA Library, Christelle Ferra, 324172

COMPREHENSIVE CARDIAC EVALUATION REVEALS NO INCREASE IN VENTRICULAR ARRHYTHMIAS IN PATIENTS ON CHRONIC IBRUTINIB THERAPY – A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES

EHA Library, Igor Aurer, 324173

PROGNOSTIC VALUE OF IGHV MUTATIONAL STATE AT DIAGNOSIS FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Cristina Bilbao-Sieyro, 324174

FEATURES OF THE DIRECT ANTIGLOBULIN TEST AND THEIR ROLE IN THE DEVELOPMENT OF IMMUNE HEMOLYSIS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Elena Poponina, 324175

COMPARATIVE ASSESSMENT OF PROGNOSTIC MODELS FOR ASYMPTOMATIC CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS IN BINET STAGE A: EVALUATION IN CHINESE HAN COHORT

EHA Library, Huayuan Zhu, 324176

FEASIBILITY OF MEASURING ADHERENCE TO ORAL ONCOLYTICS IN ROUTINE CLINICAL PRACTICE: A PILOT STUDY IN OLDER ADULTS WITH LYMPHOID DISORDERS

EHA Library, Othman Salim Akhtar, 324177

PROGNOSTIC VALUE OF APOLIPOPROTEIN A IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Xiaoya Yun, 324178

THЕ EFFICACY OF FRONT-LINE CHEMOIMMUNOTHERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE, AND RITUXIMAB (FCR) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN REAL CLINICAL PRACTICE

EHA Library, Elena Kataeva, 324179

PATIENT PERSPECTIVES OF CHRONIC LYMPHOCYTIC LEUKEMIA & DISEASE RELATED OUTCOMES – A QUALITATIVE STUDY

EHA Library, Drupad HS, 324180

OUTCOMES IN PATIENTS WITH FOLLICULAR LYMPHOMA AND CHRONIC LYMPHOID LEUKEMIA RECEIVING OBINUTUZUMAB, IN THE SETTING OF COVID19 INFECTION

EHA Library, Nora Çollaku, 324181

ATYPICAL CHRONIC LYMPHOCYTIC LEUKEMIA: A COMPARATIVE MORPHOLOGICAL AND IMMUNOPHENOTYPIC STUDY

EHA Library, Margarita Guenova, 324182

PROSID STUDY: EVALUATING EFFICACY AND SAFETY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) 10% IN PRIMARY INFECTION PROPHYLAXIS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA – STUDY DESIGN

EHA Library, Oliver Cornely, 324183

PRETREATMENT NEUTROPENIA IN CLL PATIENTS IS ASSOCIATED WITH HIGH INFECTION RISK AND PREDICTS TREATMENT INITIATION WITHIN ONE YEAR.

EHA Library, Odit Gutwein, 324184

SUBCUTANEOUS IMMUNOGLOBULINS USE IN IMMUNODEFICIENCY SECONDARY TO CHRONIC LYMPHOCYTIC LEUKAEMIA: MONOCENTRIC EXPERIENCE IN COVID-19 ERA

EHA Library, Idanna Innocenti, 324185

EVALUATION OF ADVERSE EFFECTS OF IBRUTINIB: EXPERIENCE FROM A NORTHERN HOSPITAL OF SPAIN

EHA Library, Laura Escalada González, 324186

CD38 EXPRESSION AND CD19/CD5 CO-EXPRESSION IN CLL PATIENTS WITH DIFFERENT RESPONSES TO IMMUNOCHEMOTHERAPY

EHA Library, Tetiana Perekhrestenko, 324187

TYROSINE KINASE INHIBITORS DOWNREGULATE MIRNA EXPRESSION IN K562 CELL LINE

EHA Library, Julian Matias Freue, 324188

PATTERN OF MINIMAL RESIDUAL DISEASE IN TUNISIAN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Rim Frikha, 324189

MI-30-B AS A HOUSEKEEPING GENE POR MIRNA QPCR QUANTIFICATION IN CHRONIC MYELOID LEUKEMIA

EHA Library, Julian Matias Freue, 324190

STUDY OF TELOMERE LENGTH IN PATIENTS WITH CHRONIC MYELOLEUKOSIS

EHA Library, Anna Lyamkina, 324191

PULMONARY HYPERTENSION IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-TREATED PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Ik-Chan Song, 324192

KARYOTYPING CML PATIENTS IN TANZANIA USING DRY SPOT CARDS: A FEASIBLE AND NECESSARY DIAGNOSTIC PERFORMANCE FOR BETTER TREATMENT OUTCOME

EHA Library, Oliver Henke, 324193

E13A2, E14A2 TRANSCRIPTS: DO THEY HAVE A DIFFERENT IMPACT ON OUTCOME IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA?

EHA Library, Maria Garofalaki, 324194

CHRONIC MYELOID LEUKEMIA – THE CHALLENGE OF FRONTLINE TKI SELECTION 20 YEARS AFTER IMATINIB

EHA Library, Ioannis TSONIS, 324195

A MULTICENTER REAL-WORD EVIDENCE STUDY IN THE SWISS TREATMENT LANDSCAPE OF CHRONIC MYELOID LEUKEMIA

EHA Library, Stefan Balabanov, 324196

IMPACT OF LOW-DOSES TKIS IN THE RESPONSE OF CHRONIC PHASE CML PATIENTS: A 20-YEAR RETROSPECTIVE ANALYSIS.

EHA Library, Lucia Martínez Tobar, 324197

RETROSPECTIVE REAL-WORLD COMPARISON OF CLINICAL AND ECONOMIC BURDEN BETWEEN FIRST-GENERATION AND SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKIS) IN CHRONIC MYELOID LEUKEMIA (CML)

EHA Library, Alexander Russell-Smith, 324198

TREATMENT SELECTION IN CML: EFFECT OF ONLINE EDUCATION ON CLINICIAN KNOWLEDGE AND CONFIDENCE

EHA Library, Amanda Taylor, 324199

CLINICAL CHARACTERISTICS, DISEASE EVOLUTION AND SURVIVAL IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA, BCR-ABL-1+ AND MUTATION T315I

EHA Library, Veselina Goranova, 324200

TREATMENT OF CHRONIC MYELOID LEUKEMIA IN CHILDREN WITH TYROSIN KINASE INHIBITORS

EHA Library, Nihal karadaş, 324201

QTC PROLONGATION AND SUDDEN CARDIAC DEATH AS A MANIFESTATION OF CARDIOTOXICITY

EHA Library, Lyudmila Makeeva, 324202

THE DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA: THE IMPACT OF ELN GUIDELINES ON CLINICAL PRACTICE IN A DISTRICT GENERAL HOSPITAL

EHA Library, Muttuswamy Sivakumaran, 324203

DOSE REDUCTION OF ITKS IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. RETROSPECTIVE STUDY OF A SINGLE CENTER EXPERIENCE: SAFETY, EFFICIENCY AND ECONOMIC IMPACT.

EHA Library, Fernando Marco De Lucas, 324204

DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CML WITH DEEP MOLECULAR RESPONSE IN SOUTH OF TUNISIA

EHA Library, Rahma Mallek, 324205

PARAPROTEINEMIA PREVALENCE AND CHARACTERISTICS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Tamar Berger, 324206

CHRONIC MYELOID LEUKEMIA WITH THREE-WAY TRANSLOCATION T(4;9;22) AND MULTIPLE MYELOMA – A RARE CASE OF COMORBIDITY

EHA Library, Nina Petkova, 324207

CHRONIC MYELOID LEUKEMIA AS A SECONDARY MALIGNANCY IN A PATIENT WITH SPLENIC MARGINAL ZONE LYMPHOMA: A CASE REPORT

EHA Library, Hong-Hui Huang, 324208

FISH VERSUS REAL-TIME QUANTITATIVE PCR FOR MONITORING OF MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKAEMIA PATIENTS ON TYROSINE KINASE INHIBITOR THERAPY

EHA Library, Ahmed Maseh Haidary, 324209

COMPLETE REMISSION OF PSORIASIS IN CML LADY TREATED WITH DASATINIB: JOYFUL EXPERIENCE

EHA Library, Noha Eisa, 324210

CHRONIC MYELOID LEUKEMIA: ATYPICAL PRESENTATION WITH ISOLATED EXTREME THROMBOCITOSIS

EHA Library, Julian Matias Freue, 324211

COMPLEX CYTOGENETIC ABNORMALITIES IN CHRONIC MYELOID LEUKEMIA RESULTING IN EARLY PROGRESSION TO BLAST CRISIS: A CASE REPORT

EHA Library, Ahmed Maseh Haidary, 324212

NEXT-GENERATION OSMOTIC GRADIENT EKTACYTOMETRY: AN ESSENTIAL STEP FOR THE DIAGNOSIS OF RED BLOOD CELL MEMBRANE DISORDERS

EHA Library, Anne-Sophie Adam, 324213

DIAGNOSTIC IMPORTANCE OF BONE MARROW ASPIRATION IN CHILDREN WITH ANEMIA OF UNKNOWN ETIOLOGY

EHA Library, Zaza Mtvarelidze, 324214

CLINICAL MANIFESTATIONS AND COMPLICATIONS IN PEOPLE WITH HEMOGLOBIN C DISEASE

EHA Library, Anna Paloma Martins Rocha Ribeiro, 324215

PROSPECTIVE ANALYSIS OF NEWLY DIAGNOSED AUTOIMMUNE HEMOLYTIC ANEMIA: A SINGLE CENTER STUDY

EHA Library, Drazen Pulanic, 324216

EPIDEMIOLOGICAL CHARACTERS OF ADULT EGYPTIAN AUTO IMMUNE HEAMOLYTIC ANEMIA PATIENTS: A SINGLE CENTER EXPERIENCE

EHA Library, Yasmine Shaaban, 324217

HEMOLYTIC ANAEMIA COMPLICATING PREGNANCY

EHA Library, Farha Ahmed Payyanil Karlath, 324218

GENETICALLY ENGINEERED IPSC-DERIVED NK CELLS AS A PROMISING CLINICAL DRUG CANDIDATE FOR THE TREATMENT OF B CELL MALIGNANT LYMPHOMA

EHA Library, Yangbin Gao, 324219

LIR-1 EDUCATES EXPANDED HUMAN NK CELLS AND DEFINES A UNIQUE NK CELL SUBSET WITH POTENT ADCC CAPACITY ATTRACTIVE FOR CANCER IMMUNOTHERAPY ACROSS HLA BARRIERS

EHA Library, Caroline Leijonhufvud, 324220

A PAN-CANCER ANALYSIS OF THE SUPPRESSOR ROLE OF ACETYL-COA ACETYLTRANSFERASE 1 IN TUMORS

EHA Library, Xinting Hu, 324221

THE IMPLEMENTATION OF BLOOD CANCER BIOBANKING IN GALWAY UNIVERSITY HOSPITAL

EHA Library, Annmarie Wrafter, 324222

REAL-WORLD DRUG USE AND COMPLEMENTARY AND ALTERNATIVE MEDICINES PRACTICE IN LYMPHOMA PATIENTS TREATED WITH CAR T CELLS IN A FRENCH UNIVERSITY HOSPITAL

EHA Library, Catherine Rioufol, 324223

SECONDARY HYPERPARATHYROIDISM AND ERYTHROPOETIN-STIMULATING-AGENT REFRACTORY ANEMIA: A CASE OF REVERSIBLE TRANSFUSION DEPENDENCE

EHA Library, Bilal Ashraf, 324224

A POSSIBLE NEW MUTATION IN DNMT3A AS A MARKER OF CLONAL HEMATOPOIESIS

EHA Library, Pavel Lipilkin, 324225

SPONTANEOUS APOPTOSIS IN THE CULTURE OF BONE MARROW`S MESENCHYMAL STROMAL CELLS

EHA Library, Maria Butolina, 324226

LATE TOXICITIES IN CLASSICAL HODGKIN LYMPHOMA AND DIFFUSE LARGE B-CELL LYMPHOMA SURVIVORS AND LONG-TERM MONITORING: A SERIES OF SYSTEMATIC REVIEWS OF THE FONDAZIONE ITALIANA LINFOMI

EHA Library, Carla Minoia, 324227

RISK FACTORS FOR THE OCCURRENCE OF BLEOMYCIN-INDUCED LUNG TOXICITY IN THE ERA OF POSITRON EMISSION TOMOGRAPHY.

EHA Library, Selim Jennane, 324228

PROGNOSTIC FACTORS OF WORSE SURVIVAL IN NEWLY DIAGNOSED ADVANCED-STAGE HODGKIN LYMPHOMA IN TAIWAN: A NATIONWIDE RETROSPECTIVE STUDY

EHA Library, Tran-Der Tan, 324229

BRENTUXIMAB VEDOTIN IN COMBINATION WITH NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE IN NEWLY DIAGNOSED PATIENTS WITH ADVANCED HODGKIN LYMPHOMA (SGN35-027, TRIAL IN PROGRESS)

EHA Library, Ian W. Flinn, 324230

OUTCOMES AFTER INITIAL REFUSAL OF CURATIVE TREATMENT IN PATIENTS WITH HODGKIN LYMPHOMA IN BRITISH COLUMBIA

EHA Library, Manik Chahal, 324231

RETROSPECTIVE STUDY TO DESCRIBE TREATMENT PATHWAYS, OUTCOMES, AND RESOURCE USE IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA (B-HOLISTIC): RESULTS FROM THE SUBGROUP ANALYSIS OF PATIENTS FROM CHINA

EHA Library, Yuqin Song, 324232

THE PARTICULARITY OF MANAGEMENT OF PEDIATRIC HODGKIN LYMPHOMA IN TUNISIA: MONOCENTRIC STUDY

EHA Library, Raoudha Mansouri, 324233

LONG-TERM OUTCOME OF HODGKIN’S LYMPHOMA CASES IN A POPULATION-BASED CANCER CENTER

EHA Library, Salem Alshemmari, 324234

HODGKIN'S LYMPHOMA IN ADOLESCENTS TREATED WITH ABVD

EHA Library, S.M.Amine BENLAZAR, 324235

EARLY DISEASE PROGRESSION PREDICTS SHORTER SURVIVAL IN PATIENTS TREATED FOR HODGKIN LYMPHOMA.

EHA Library, S.M.Amine BENLAZAR, 324236

INTERIM PET BASED OMISSION OF RADIOTHERAPY OR INTENSIFICATION OF CHEMOTHERAPY IN YOUNGER PATIENTS WITH LOCALIZED STAGE CLASSICAL HODGKIN LYMPHOMA: PRELIMINARY EXPERIENCE FROM A SINGLE REFERRAL CENTER

EHA Library, Marina Belia, 324237

ACUTE NEUROLOGIC DETERIORATION FOLLOWING THREE DOSES OF BRENTUXIMAB-VEDOTIN IN A PATIENT WITH CHARCOT-MARIE-TOOTH DISEASE

EHA Library, HARIDIAN DE LA NUEZ MELIAN, 324238

BULKY MEDIASTINAL DISEASE IN HODGKIN LYMPHOMA: THERAPEUTIC OUTCOMES OF ABVD VERSUS BEACOPP ESCALATED REGIMEN IN A SINGLE TUNISIAN CENTER

EHA Library, Faten kallel, 324239

IS THERE ANY CORRELATION BETWEEN THE HISTORY OF FAMILIAL NEOPLASIA AND THE DESCRIPTIVE AND PROGRESSIVE PROFILE OF HODGKIN LYMPHOMAS? 4-YEAR COHORT STUDY

EHA Library, Talbi Faiza, 324240

THERAPEUTIC RESULTS OF A TUNISIAN PROSPECTIVE NON-RANDOMIZED ADULT HODGKIN LYMPHOMA STUDY: SINGLE-INSTITUTION EXPERIENCE ABOUT 73 ADULT PATIENTS

EHA Library, Faten kallel, 324241

A PHASE III TRIAL (GO42909) EVALUATING MOSUNETUZUMAB IN COMBINATION WITH LENALIDOMIDE (M-LEN) VERSUS RITUXIMAB-LENALIDOMIDE (R-LEN) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

EHA Library, Christian W. Scholz, 324242

TRIAL IN PROGRESS: A PHASE 2, SINGLE-ARM, OPEN-LABEL, MULTICENTER STUDY OF TAZEMETOSTAT IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

EHA Library, Krish Patel, 324243

THE PROGNOSTIC NUTRITIONAL INDEX (PNI) IS AN INDEPENDENT PREDICTOR OF OVERALL SURVIVAL IN OLDER PATIENTS WITH FOLLICULAR LYMPHOMA

EHA Library, Pablo Mozas, 324244